Discount Vitamins & Herbs

- Products by Category
- Alphabetic Product Listing

Home Go Shopping Specials Product Info Health News FAQs About Us Links Site Map

Hyaluronic Acid Center, Neptune Krill Oil & Rejuvenation Science for Doctors

Tuesday, March 23, 2010

Low Vitamin D Level Increases Risk of Kidney Failure 2.6 Times

Low levels of vitamin D may account for up to 60% of the elevated risk of end stage renal disease (ESRD) in African Americans according to a report in the December 2009 issue of the American Society of Nephrology. Researchers analyzed a nationwide sample of 13,000 americans, including measurements of vitamin D levels. The participants with the lowest vitamin D levels were 2.6 times as likely to end up on dialysis compared to those with higher levels.

For further information, view the full article on vitamin D levels and the risk of end stage kidney disease.

Friday, January 01, 2010

High CRP and Normal LDL Are Long-Term Risk Factors for Heart Disease, Stroke and Death

New research shows a long-term benefit in screening people for c-reactive protein (CRP), a marker for inflammation, even if they have normal levels of bad cholesterol, because of increased long-term risk for heart attack, stroke and death.

"The new study analyzed patients' risk over an average of seven years to determine that CRP is, in fact, a long-term indicator of cardiovascular risk," said Ballantyne. "This is important because approximately one in five ment over 50 and women over 60 has a similar profile of increased CRP, but normal LDL."

Read details of the high CRP, normal LDL cardiovascular risk study.

Wednesday, November 04, 2009

Low Vitamin D Levels Explains Most ESRD Risk in African Americans

Low levels of vitamin D may account for nearly 60 percent of the elevated risk of end-stage renal disease (ESRD) in African Americans. "Our study adds to previous evidence linking vitamin D deficiency to the progression of kidney disease and the need for dialysis."

We found that 25(OH)D deficiency was responsible for about 58 percent of the excess risk for ESRD experienced by African Americans. Vitamin D deficiency is a very common problem in the United States. In recent years, studies have linked low vitamin D to many different health problems, including diabetes, high blood pressure, cancers, and heart disease. The new results add to previous evidence that low 25(OH)D levels are an important risk factor for ESRD.

View details of this kidney disease vitamin D study.

Wednesday, October 21, 2009

N-Acetyl Cysteine Effective for Acute Liver Failure

The antidote for acute liver failure caused by acetaminophen poisoning also can treat acute liver failure due to most other causes if given before severe injury occurs. Acute liver failure occurs when cells in the liver die quickly, resulting in toxins being released into the bloodstream and brain. Patients often end up in a hepatic coma as a result of toxins not being cleared by the failing liver. Known causes of acute liver failure include autoimmune hepatitis, drug-induced liver injury, hepatitis A and B, and acetaminophen poisoning.

Researchers found that acute liver failure patients in early stages of hepatic comas, when treated with the medicine N-acetylcysteine (NAC), were nearly 2.5 times more likely to survive than those treated only with a placebo.

Read more about this N-Acetyl Cysteine acute liver failure study.

Saturday, October 10, 2009

Future Diabetes Treatment May Use Resveratrol to Target the Brain

Resveratrol, a molecule found in red grapes, has been shown to improve diabetes when delivered orally to rodents. The brain plays a key role in mediating resveratrol’s anti-diabetic actions, potentially paving the way for future orally-delivered diabetes medications that target the brain.

“We know that sirtuins are expressed in parts of the brain known to govern glucose metabolism, so we hypothesized that the brain could be mediating resveratrol’s anti-diabetic actions,” said Roberto Coppari, PhD, of the University of Texas Southwestern Medical Center.

These findings may lead to new strategies in the fight against type 2 diabetes.

View details of this resveratrol diabetes study.

Sunday, October 04, 2009

Kudzu May Lower Blood Sugar, Blood Pressure, Cholesterol

Kudzu may prove to be a valuable dietary supplement for metabolic syndrome, a condition that affects 50 million Americans, say researchers at the University of Alabama at Birmingham (UAB).

The researchers say studies on animal models showed that substances called isoflavones found in kudzu root improved regulation of contributors to metabolic syndrome, including blood pressure, high cholesterol and blood glucose.

An excessive amount of glucose in the blood is linked to both diabetes and obesity. Wyss says puerarin seems to regulate glucose by steering it to places where it is beneficial, such as muscles, and away from fat cells and blood vessels.

View details of this kudzu blood sugar, blood pressure, cholesterol, metabolic syndrome study.

Tuesday, August 25, 2009

Why Low Vitamin D Raises Heart Disease Risks in Diabetics

Low levels of vitamin D are known to nearly double the risk of cardiovascular disease in patients with diabetes, and researchers at Washington University School of Medicine in St. Louis now think they know why.

They have found that diabetics deficient in vitamin D can't process cholesterol normally, so it builds up in their blood vessels, increasing the risk of heart attack and stroke. The new research has identified a mechanism linking low vitamin D levels to heart disease risk and may lead to ways to fix the problem, simply by increasing levels of vitamin D.

View details of this vitamin D diabetic heart disease risk study.